Jamp-clopidogrel : May Contain Overweight Or Underweight Tablets
JAMP-Clopidogrel tablets are being recalled across Canada because some tablets may be overweight or underweight, which means they could contain incorrect amounts of the active ingredient. This is a Class I recall, indicating a serious quality issue. The recall affects all JAMP-Clopidogrel products distributed in Canada.
- Product
- JAMP-Clopidogrel
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-09-06
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/711397bf-cbbb-45b5-b830-0cb7ebe2168d